D.E. Shaw & Co
GRDN

D.E. Shaw & Co’s Guardian Pharmacy Services GRDN Stock Holding History

D.E. Shaw & Co’s Portfolio GRDN Stock Details GRDN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.85M Sell
75,683
-10,846
-13% -$354K ﹤0.01% 2634
2025
Q4 		$2.6M Buy
86,529
+39,981
+86% +$1.13M ﹤0.01% 2834
2025
Q3 		$1.22M Buy
+46,548
New +$1.11M ﹤0.01% 3338

Other funds holding GRDN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VCM
Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

D.E. Shaw & Co's GRDN Position: Q1 2026 in Review

D.E. Shaw & Co reduced its Guardian Pharmacy Services (GRDN) stake by 13% in Q1 2026, selling an estimated $354K and leaving 75,683 shares worth $2.85M. The position accounts for ﹤0.01% of the portfolio, ranked #2634.

D.E. Shaw & Co first reported a position in GRDN in Q3 2025 and has held it in 3 quarters since. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

  • D.E. Shaw & Co held 75,683 shares of Guardian Pharmacy Services worth $2.85M as of Q1 2026.
  • D.E. Shaw & Co sold 10,846 Guardian Pharmacy Services shares in Q1 2026, an estimated $354K.
  • Guardian Pharmacy Services made up ﹤0.01% of D.E. Shaw & Co's portfolio in Q1 2026, its #2634 holding.
  • D.E. Shaw & Co first reported a position in Guardian Pharmacy Services in Q3 2025 and has held it in 3 quarters since.
  • 171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on D.E. Shaw & Co's 13F filing for Q1 2026, filed 15 May 2026.